Karine Lacombe, MD, PhD

Sorbonne Inserm UMR-S1136, Hôpital St Antoine, AP-HP, Paris, France; F-CRIN, I REIVAC/COVIREIVAC, France, France

Disclosure(s): Gilead: Advisor/Consultant; Janssen: Grant/Research Support; MSD: Grant/Research Support; ViiV Healthcare: Grant/Research Support

Poster(s):

• 1954 - Immunogenicity against SARS CoV-2 ancestral strain and variants of two new COVID-19 recombinant adjuvanted vaccines compared to BNT162b2 as a third dose following two doses of BNT162b2: a single-blinded multicenter randomized controlled trial
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET